| Business Summary | | Ophthalmic
Imaging
Systems
is
engaged
in
the
business
of
designing,
developing,
manufacturing
and
marketing
digital
imaging
systems
and
image
enhancement
and
analysis
software
for
use
by
practitioners
in
the
ocular
health
field.
The
Company's
products
are
used
for
a
variety
of
standard
diagnostic
test
procedures
performed
in
most
eye
care
practices.
The
current
flagship
products
in
the
Company's
angiography
line
are
its
digital
imaging
systems,
the
WinStation
1024
and
WinStation
640.
These
WinStation
products
are
targeted
primarily
at
retinal
specialists
and
general
ophthalmologists
in
the
diagnosis
and
treatment
of
retinal
diseases
and
other
ocular
pathologies. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | OISI
designs,
develops,
manufactures
and
markets
digital
imaging
systems,
image
enhancement
and
analysis
software
for
use
by
practitioners
in
the
ocular
health
field.
For
the
comparable
three
months
ended
3/31/01,
revenues
increased
7%
to
$1.7
million.
Net
loss
before
extraordinary
item
totaled
$51
thousand
vs.
an
income
of
$2
thousand.
Revenues
reflect
the
commencement
of
deliveries
of
the
Company's
products.
Net
loss
reflects
increased
R&D
expenses. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
1,332;
after
tax
earnings
were
-130. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | The
Company
has
no
officers. | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|